• Markets
  • icon
  • Companies
BGT · ASX

Bio-Gene Technology Ltd. (ASX:BGT)

AU$0.05

 0.0 (0.0%)
ASX:Live
14/06/2024 11:22:37 AM
Near Support HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

BGT Overview

BGT Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About BGT

Telephone

N/A

Address

Description

Bio-Gene Technology Ltd. engages in the research and development of the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. Its novel platform technology is based on occurring beta-triketones, a type of chemistry that may offer solutions for insect management control in animal health and crop protection as well as in public health applications. The company was founded on November 8, 1995 and is headquartered in Melbourne, Australia.

BGT Price Chart

Key Stats

Market Cap

AU$10.07M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.04 - 0.1

Trade Value (12mth)

AU$934.00

1 week

0%

1 month

-18.03%

YTD

-15.25%

1 year

-43.18%

All time high

0.3499999940395355

Key Fundamentals

EPS 3 yr Growth

13.600%

EBITDA Margin

%

Operating Cashflow

-$3m

Free Cash Flow Return

-69.00%

ROIC

-65.20%

Interest Coverage

N/A

Quick Ratio

6.20

Other Data

Shares on Issue (Fully Dilluted)

178m

HALO Sector

Next Company Report Date

22-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BGT Announcements

Latest Announcements

Date Announcements

17 May 24

Gene Technology Ltd. - Company Secretary Appointment/Resignation

×

Gene Technology Ltd. - Company Secretary Appointment/Resignation

06 May 24

Gene Technology Ltd. - Notification of cessation of securities - BGT

×

Gene Technology Ltd. - Notification of cessation of securities - BGT

29 April 24

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

×

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

08 April 24

Gene Technology Ltd. - Appointment of CFO and Joint Company Secretary

×

Gene Technology Ltd. - Appointment of CFO and Joint Company Secretary

05 March 24

Gene Technology Ltd. - Investor Webinar - FY24 Half Year Review

×

Gene Technology Ltd. - Investor Webinar - FY24 Half Year Review

26 February 24

Gene Technology Ltd. - Appendix 4D - Half Year Accounts - 31 December 2023

×

Gene Technology Ltd. - Appendix 4D - Half Year Accounts - 31 December 2023

29 January 24

Gene Technology Ltd. - Appendix 4C - 31 December 2023

×

Gene Technology Ltd. - Appendix 4C - 31 December 2023

19 January 24

Gene Technology Ltd. - Bio-Gene Receives R&D Tax Incentive

×

Gene Technology Ltd. - Bio-Gene Receives R&D Tax Incentive

13 December 23

Gene Technology Ltd. - BGT Corporate Presentation

×

Gene Technology Ltd. - BGT Corporate Presentation

13 December 23

Gene Technology Ltd. - Investor Webinar - Prof. Catherine Hill and CEO Tim Grogan

×

Gene Technology Ltd. - Investor Webinar - Prof. Catherine Hill and CEO Tim Grogan

07 December 23

Gene Technology Ltd. - Investor Webinar - Prof. Catherine Hill and CEO Tim Grogan

×

Gene Technology Ltd. - Investor Webinar - Prof. Catherine Hill and CEO Tim Grogan

01 December 23

Gene Technology Ltd. - Bio-Gene to Present at Automic Invest 2023 Conference

×

Gene Technology Ltd. - Bio-Gene to Present at Automic Invest 2023 Conference

27 November 23

Gene Technology Ltd. - Becoming a substantial holder

×

Gene Technology Ltd. - Becoming a substantial holder

23 November 23

Gene Technology Ltd. - BGT 2023AGM - Chairman's Address

×

Gene Technology Ltd. - BGT 2023AGM - Chairman's Address

23 November 23

Gene Technology Ltd. - BGT 2023AGM - CEO's Address

×

Gene Technology Ltd. - BGT 2023AGM - CEO's Address

23 November 23

Gene Technology Ltd. - BGT 2023AGM - CEO's Presentation

×

Gene Technology Ltd. - BGT 2023AGM - CEO's Presentation

23 November 23

Gene Technology Ltd. - Results of Meeting

×

Gene Technology Ltd. - Results of Meeting

23 November 23

Gene Technology Ltd. - Application for quotation of securities - BGT

×

Gene Technology Ltd. - Application for quotation of securities - BGT

23 November 23

Gene Technology Ltd. - Cleansing Statement

×

Gene Technology Ltd. - Cleansing Statement

23 November 23

Gene Technology Ltd. - Notification of cessation of securities - BGT

×

Gene Technology Ltd. - Notification of cessation of securities - BGT

23 November 23

Gene Technology Ltd. - Change of Director's Interest Notice - A Ding

×

Gene Technology Ltd. - Change of Director's Interest Notice - A Ding

23 November 23

Gene Technology Ltd. - Change of Director's Interest Notice - A Guthrie

×

Gene Technology Ltd. - Change of Director's Interest Notice - A Guthrie

23 November 23

Gene Technology Ltd. - Change of Director's Interest Notice - C Ramsey

×

Gene Technology Ltd. - Change of Director's Interest Notice - C Ramsey

23 November 23

Gene Technology Ltd. - Change of Director's Interest Notice - T Grogan

×

Gene Technology Ltd. - Change of Director's Interest Notice - T Grogan

BGT Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.02 -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.02 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -8.0 -8.6 3.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -18.9 -5.6 -26.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock -7.8 -10.0 -25.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.04 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.03 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -38.1 30.7 -49.9 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 137 153 168 Lock Lock Lock
Basic m Lock Lock Lock Lock 137 153 168 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -49.0 611.9 -66.5 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 3 4 3 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 23.4 261.5 -191.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -176.6 40.1 -109.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 277 60 210 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -3 -3 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -1.2 -15.2 -6.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4,664.6 -754.7 -2,400.7 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -3 -3 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -1.1 -14.6 -6.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4,751.2 -764.5 -2,431.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -3 -3 -4 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.0 -21.6 -6.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,827.3 -653.8 -2,074.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -2 -2 -3 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 4 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -2 -2 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -11.2 -9.4 -63.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -29.2 -4.5 -22.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 4 6 3 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 5 7 4 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -4 -6 -3 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Equity $m Lock Lock Lock Lock 4 6 3 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 4 6 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -29.3 47.6 -48.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -47.9 -39.9 -80.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -56.4 -46.5 -96.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -58.0 -64.8 -76.5 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -46.8 -55.4 -65.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -35.6 -37.9 -69.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.3 1.9 0.8 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -92.6 -101.2 -92.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 7.9 6.9 6.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 7.9 6.9 6.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 84.3 90.6 83.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -308.0 -197.5 -570.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.1 0.9 0.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.1 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 140.7 49.1 79.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -4,642.7 -751.2 -2,373.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -58.1 -45.8 -92.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -47.9 -39.9 -80.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.2 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -56.4 -46.5 -96.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -56.4 -46.5 -96.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 2,934.7 393.9 1,080.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 2,934.7 393.9 1,080.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 291.8 209.8 196.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 2,642.9 184.0 884.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

%

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BGT Shortsell

Frequently Asked Questions

The current share price of Bio-Gene Technology Ltd. (BGT:ASX) is AU$0.05.
The 52-week high share price for Bio-Gene Technology Ltd. (BGT:ASX) is AU$0.10.
The 52-week low share price for Bio-Gene Technology Ltd. (BGT:ASX)? is AU$0.04.
Bio-Gene Technology Ltd. (BGT:ASX) does not pay a dividend.
Bio-Gene Technology Ltd. (BGT:ASX) does not pay a dividend.
Bio-Gene Technology Ltd. (BGT:ASX) does not offer franking credits.
Bio-Gene Technology Ltd. (BGT:ASX) is classified in the Industrials.
The current P/E ratio for Bio-Gene Technology Ltd. (BGT:ASX) is .